Dr Lal Pathlabs' Stock Declines by -3.33%, Underperforms Sector According to MarketsMOJO.

Dr Lal Pathlabs, a leading hospital and healthcare services company, saw a decline in its stock price by -3.33% on October 24, 2024. This performance was deemed as underperforming the sector by -3% according to MarketsMOJO, a leading stock market analysis platform.

The stock has been on a consecutive fall for the last 2 days, with a total decline of -4.81% during this period. However, there was a slight positive start to the day as the stock opened with a gain of 2.93%. The intraday high for the stock was Rs 3377.65, showing a 3.85% increase, while the intraday low was Rs 3122.25, indicating a -4% decrease.

When looking at the moving averages, it can be seen that the stock is currently higher than the 100-day and 200-day moving averages. However, it is lower than the 5-day, 20-day, and 50-day moving averages.

In comparison to the overall market performance, Dr Lal Pathlabs' stock has underperformed. On the day of October 24, the stock's performance was -2.79% while the Sensex's performance was 0.02%. In the last month, the stock's performance was -5.90% compared to the Sensex's -5.67%.

Overall, the stock's performance has been on a decline, but it is still higher than the moving averages. Investors are advised to hold their positions on the stock, according to MarketsMOJO.